Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Total article views   HTML views PDF downloads Totals
10,398 Dovepress* 9,652+ 1,466 11,118
PubMed Central* 746 306 1,052
Totals 10,398 1,772 12,170
*Since 28 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar